PET-PSMA is a relatively new molecular imaging technique that, in recent years, has accumulated substantial evidence with various PSMA ligands, establishing itself as an effective tool for restaging and detecting distant disease in patients with biochemical recurrence of prostate cancer. Here, FOLH1 is linked to prostate carcinoma.